Drug Shortage Report for DOCETAXEL INJECTION USP

Last updated on 2025-05-07 History
Report ID 256814
Drug Identification Number 02361957
Brand name DOCETAXEL INJECTION USP
Common or Proper name DOCETAXEL INJECTION USP
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) DOCETAXEL
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 16 ML VIAL
ATC code L01CD
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2025-05-19
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Anticipated shortage
Updated date 2025-05-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: [email protected]

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2025-05-07 French Compare
v1 2025-05-07 English Compare

Showing 1 to 2 of 2